nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC1—Vemurafenib—skin cancer	0.0623	0.0817	CbGbCtD
Verapamil—ABCC10—Docetaxel—skin cancer	0.0554	0.0726	CbGbCtD
Verapamil—ABCG2—Vismodegib—skin cancer	0.0527	0.0692	CbGbCtD
Verapamil—ABCC3—Fluorouracil—skin cancer	0.0456	0.0598	CbGbCtD
Verapamil—ABCG2—Vemurafenib—skin cancer	0.0417	0.0547	CbGbCtD
Verapamil—ABCC1—Dactinomycin—skin cancer	0.0414	0.0543	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—skin cancer	0.0394	0.0516	CbGbCtD
Verapamil—ABCC4—Fluorouracil—skin cancer	0.0348	0.0457	CbGbCtD
Verapamil—CYP1A2—Imiquimod—skin cancer	0.0314	0.0411	CbGbCtD
Verapamil—CYP2C8—Vismodegib—skin cancer	0.0281	0.0368	CbGbCtD
Verapamil—ABCG2—Dactinomycin—skin cancer	0.0277	0.0363	CbGbCtD
Verapamil—CYP2C19—Vismodegib—skin cancer	0.0236	0.0309	CbGbCtD
Verapamil—ABCC1—Docetaxel—skin cancer	0.0214	0.028	CbGbCtD
Verapamil—CYP2C9—Vismodegib—skin cancer	0.0196	0.0257	CbGbCtD
Verapamil—ABCB1—Vismodegib—skin cancer	0.019	0.0249	CbGbCtD
Verapamil—ABCG2—Fluorouracil—skin cancer	0.0187	0.0246	CbGbCtD
Verapamil—CYP1A2—Vemurafenib—skin cancer	0.0172	0.0225	CbGbCtD
Verapamil—CYP3A4—Temozolomide—skin cancer	0.0164	0.0216	CbGbCtD
Verapamil—CYP3A4—Imiquimod—skin cancer	0.0164	0.0216	CbGbCtD
Verapamil—ABCC2—Docetaxel—skin cancer	0.0158	0.0207	CbGbCtD
Verapamil—ABCG2—Docetaxel—skin cancer	0.0143	0.0188	CbGbCtD
Verapamil—CYP2D6—Vemurafenib—skin cancer	0.0142	0.0186	CbGbCtD
Verapamil—CYP1A2—Dacarbazine—skin cancer	0.0132	0.0173	CbGbCtD
Verapamil—CACNA1S—pes—skin cancer	0.013	0.208	CbGeAlD
Verapamil—CYP3A4—Vismodegib—skin cancer	0.0114	0.0149	CbGbCtD
Verapamil—CYP3A7—Docetaxel—skin cancer	0.0106	0.0139	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0106	0.0139	CbGbCtD
Verapamil—ABCB1—Dactinomycin—skin cancer	0.00999	0.0131	CbGbCtD
Verapamil—CYP2C8—Fluorouracil—skin cancer	0.00998	0.0131	CbGbCtD
Verapamil—CYP3A4—Vemurafenib—skin cancer	0.00901	0.0118	CbGbCtD
Verapamil—CYP3A5—Docetaxel—skin cancer	0.00792	0.0104	CbGbCtD
Verapamil—CYP1A2—Fluorouracil—skin cancer	0.00772	0.0101	CbGbCtD
Verapamil—CYP2C9—Fluorouracil—skin cancer	0.00696	0.00913	CbGbCtD
Verapamil—ABCB1—Docetaxel—skin cancer	0.00516	0.00676	CbGbCtD
Verapamil—CACNA1A—nerve—skin cancer	0.004	0.0643	CbGeAlD
Verapamil—CYP3A4—Docetaxel—skin cancer	0.00309	0.00405	CbGbCtD
Verapamil—CACNA1D—ear—skin cancer	0.003	0.0481	CbGeAlD
Verapamil—CACNB4—nipple—skin cancer	0.00238	0.0382	CbGeAlD
Verapamil—CACNB3—nipple—skin cancer	0.00182	0.0293	CbGeAlD
Verapamil—CACNA1B—connective tissue—skin cancer	0.00157	0.0253	CbGeAlD
Verapamil—CACNA1F—head—skin cancer	0.00151	0.0243	CbGeAlD
Verapamil—CACNB3—mammalian vulva—skin cancer	0.00106	0.0171	CbGeAlD
Verapamil—CACNB4—head—skin cancer	0.000995	0.016	CbGeAlD
Verapamil—CACNA1A—head—skin cancer	0.00095	0.0153	CbGeAlD
Verapamil—ABCC1—hair follicle—skin cancer	0.000933	0.015	CbGeAlD
Verapamil—CACNA1B—head—skin cancer	0.000927	0.0149	CbGeAlD
Verapamil—CACNB3—female reproductive system—skin cancer	0.000912	0.0146	CbGeAlD
Verapamil—ABCC10—nipple—skin cancer	0.000895	0.0144	CbGeAlD
Verapamil—CYP2C18—mammalian vulva—skin cancer	0.000848	0.0136	CbGeAlD
Verapamil—CACNA1I—lymph node—skin cancer	0.000846	0.0136	CbGeAlD
Verapamil—SLC22A4—neck—skin cancer	0.000832	0.0134	CbGeAlD
Verapamil—CACNA1G—head—skin cancer	0.000828	0.0133	CbGeAlD
Verapamil—CACNB1—head—skin cancer	0.000794	0.0128	CbGeAlD
Verapamil—CACNB3—head—skin cancer	0.000762	0.0122	CbGeAlD
Verapamil—CACNA1C—connective tissue—skin cancer	0.000701	0.0113	CbGeAlD
Verapamil—CACNA1B—lymph node—skin cancer	0.000649	0.0104	CbGeAlD
Verapamil—CACNA1H—female reproductive system—skin cancer	0.000649	0.0104	CbGeAlD
Verapamil—ABCC1—nipple—skin cancer	0.000633	0.0102	CbGeAlD
Verapamil—KCNJ11—lymphoid tissue—skin cancer	0.000603	0.00968	CbGeAlD
Verapamil—KCNH2—nipple—skin cancer	0.000589	0.00946	CbGeAlD
Verapamil—KCNJ11—female reproductive system—skin cancer	0.000581	0.00934	CbGeAlD
Verapamil—SLC22A5—nipple—skin cancer	0.000557	0.00894	CbGeAlD
Verapamil—CACNB1—lymph node—skin cancer	0.000556	0.00893	CbGeAlD
Verapamil—CACNB3—lymph node—skin cancer	0.000533	0.00857	CbGeAlD
Verapamil—ABCC10—mammalian vulva—skin cancer	0.000523	0.00839	CbGeAlD
Verapamil—CACNB2—head—skin cancer	0.000512	0.00822	CbGeAlD
Verapamil—CYP1A2—nipple—skin cancer	0.000504	0.0081	CbGeAlD
Verapamil—CACNA1C—female reproductive system—skin cancer	0.000494	0.00794	CbGeAlD
Verapamil—KCNJ11—head—skin cancer	0.000486	0.0078	CbGeAlD
Verapamil—SLCO1B1—female reproductive system—skin cancer	0.000474	0.00761	CbGeAlD
Verapamil—Respiratory failure—Docetaxel—skin cancer	0.000466	0.00327	CcSEcCtD
Verapamil—ABCC10—lymphoid tissue—skin cancer	0.000464	0.00745	CbGeAlD
Verapamil—Nausea—Vismodegib—skin cancer	0.000462	0.00324	CcSEcCtD
Verapamil—Agitation—Imiquimod—skin cancer	0.000462	0.00323	CcSEcCtD
Verapamil—Angioedema—Imiquimod—skin cancer	0.000459	0.00321	CcSEcCtD
Verapamil—Syncope—Imiquimod—skin cancer	0.00045	0.00315	CcSEcCtD
Verapamil—Acute coronary syndrome—Bleomycin—skin cancer	0.00045	0.00315	CcSEcCtD
Verapamil—ABCC3—female reproductive system—skin cancer	0.00045	0.00722	CbGeAlD
Verapamil—Hypotension—Vemurafenib—skin cancer	0.000449	0.00315	CcSEcCtD
Verapamil—Myocardial infarction—Bleomycin—skin cancer	0.000448	0.00313	CcSEcCtD
Verapamil—ABCC10—female reproductive system—skin cancer	0.000447	0.00719	CbGeAlD
Verapamil—CACNA1D—head—skin cancer	0.000447	0.00719	CbGeAlD
Verapamil—Palpitations—Imiquimod—skin cancer	0.000444	0.00311	CcSEcCtD
Verapamil—Loss of consciousness—Imiquimod—skin cancer	0.000441	0.00309	CcSEcCtD
Verapamil—Muscular weakness—Temozolomide—skin cancer	0.000441	0.00309	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000438	0.00307	CcSEcCtD
Verapamil—Cardiac arrest—Fluorouracil—skin cancer	0.000438	0.00307	CcSEcCtD
Verapamil—Convulsion—Imiquimod—skin cancer	0.000435	0.00305	CcSEcCtD
Verapamil—Hypertension—Imiquimod—skin cancer	0.000434	0.00304	CcSEcCtD
Verapamil—Chest pain—Imiquimod—skin cancer	0.000428	0.00299	CcSEcCtD
Verapamil—Arthralgia—Imiquimod—skin cancer	0.000428	0.00299	CcSEcCtD
Verapamil—Myalgia—Imiquimod—skin cancer	0.000428	0.00299	CcSEcCtD
Verapamil—Discomfort—Imiquimod—skin cancer	0.000422	0.00296	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000422	0.00296	CcSEcCtD
Verapamil—Sweating increased—Temozolomide—skin cancer	0.000421	0.00295	CcSEcCtD
Verapamil—SLC22A4—female reproductive system—skin cancer	0.000421	0.00676	CbGeAlD
Verapamil—Dry mouth—Imiquimod—skin cancer	0.000418	0.00293	CcSEcCtD
Verapamil—Fatigue—Vemurafenib—skin cancer	0.000414	0.0029	CcSEcCtD
Verapamil—CACNA1C—head—skin cancer	0.000413	0.00663	CbGeAlD
Verapamil—Constipation—Vemurafenib—skin cancer	0.000411	0.00288	CcSEcCtD
Verapamil—Oedema—Imiquimod—skin cancer	0.00041	0.00287	CcSEcCtD
Verapamil—Hypoaesthesia—Bleomycin—skin cancer	0.000408	0.00286	CcSEcCtD
Verapamil—Pulmonary oedema—Docetaxel—skin cancer	0.000408	0.00285	CcSEcCtD
Verapamil—Infection—Imiquimod—skin cancer	0.000407	0.00285	CcSEcCtD
Verapamil—Muscular weakness—Fluorouracil—skin cancer	0.000406	0.00284	CcSEcCtD
Verapamil—Shock—Imiquimod—skin cancer	0.000403	0.00282	CcSEcCtD
Verapamil—Upper respiratory tract infection—Temozolomide—skin cancer	0.000401	0.00281	CcSEcCtD
Verapamil—SCN5A—head—skin cancer	0.0004	0.00643	CbGeAlD
Verapamil—Tachycardia—Imiquimod—skin cancer	0.0004	0.0028	CcSEcCtD
Verapamil—Pollakiuria—Temozolomide—skin cancer	0.000399	0.00279	CcSEcCtD
Verapamil—Erectile dysfunction—Temozolomide—skin cancer	0.000398	0.00279	CcSEcCtD
Verapamil—Hyperhidrosis—Imiquimod—skin cancer	0.000396	0.00277	CcSEcCtD
Verapamil—Angina pectoris—Fluorouracil—skin cancer	0.000388	0.00271	CcSEcCtD
Verapamil—Hepatitis—Dactinomycin—skin cancer	0.000382	0.00268	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000382	0.00267	CcSEcCtD
Verapamil—Flushing—Bleomycin—skin cancer	0.00038	0.00266	CcSEcCtD
Verapamil—CACNA1H—lymph node—skin cancer	0.00038	0.0061	CbGeAlD
Verapamil—Pharyngitis—Dactinomycin—skin cancer	0.000379	0.00266	CcSEcCtD
Verapamil—ABCC3—head—skin cancer	0.000376	0.00603	CbGeAlD
Verapamil—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000373	0.00262	CcSEcCtD
Verapamil—SLC6A4—female reproductive system—skin cancer	0.000373	0.00599	CbGeAlD
Verapamil—ABCC4—female reproductive system—skin cancer	0.000371	0.00596	CbGeAlD
Verapamil—Insomnia—Imiquimod—skin cancer	0.000371	0.0026	CcSEcCtD
Verapamil—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00037	0.00259	CcSEcCtD
Verapamil—ABCC1—mammalian vulva—skin cancer	0.00037	0.00594	CbGeAlD
Verapamil—Paraesthesia—Imiquimod—skin cancer	0.000368	0.00258	CcSEcCtD
Verapamil—Dyspnoea—Imiquimod—skin cancer	0.000365	0.00256	CcSEcCtD
Verapamil—Somnolence—Imiquimod—skin cancer	0.000364	0.00255	CcSEcCtD
Verapamil—Alopecia—Bleomycin—skin cancer	0.000362	0.00254	CcSEcCtD
Verapamil—Erythema multiforme—Dactinomycin—skin cancer	0.000361	0.00253	CcSEcCtD
Verapamil—Sinusitis—Temozolomide—skin cancer	0.000361	0.00253	CcSEcCtD
Verapamil—Dyspepsia—Imiquimod—skin cancer	0.000361	0.00253	CcSEcCtD
Verapamil—ABCC2—female reproductive system—skin cancer	0.000359	0.00577	CbGeAlD
Verapamil—CACNB2—lymph node—skin cancer	0.000358	0.00576	CbGeAlD
Verapamil—ABCB1—blood vessel—skin cancer	0.000357	0.00574	CbGeAlD
Verapamil—SLC22A5—skin of body—skin cancer	0.000356	0.00573	CbGeAlD
Verapamil—Flushing—Dactinomycin—skin cancer	0.000355	0.00248	CcSEcCtD
Verapamil—Hypersensitivity—Vemurafenib—skin cancer	0.000354	0.00248	CcSEcCtD
Verapamil—Fatigue—Imiquimod—skin cancer	0.000353	0.00247	CcSEcCtD
Verapamil—Pain—Imiquimod—skin cancer	0.000351	0.00245	CcSEcCtD
Verapamil—Acute coronary syndrome—Fluorouracil—skin cancer	0.00035	0.00245	CcSEcCtD
Verapamil—Myocardial infarction—Fluorouracil—skin cancer	0.000348	0.00244	CcSEcCtD
Verapamil—Hepatitis—Temozolomide—skin cancer	0.000346	0.00242	CcSEcCtD
Verapamil—Asthenia—Vemurafenib—skin cancer	0.000345	0.00241	CcSEcCtD
Verapamil—Hypoaesthesia—Temozolomide—skin cancer	0.000344	0.00241	CcSEcCtD
Verapamil—Pharyngitis—Temozolomide—skin cancer	0.000343	0.0024	CcSEcCtD
Verapamil—Oedema peripheral—Temozolomide—skin cancer	0.000341	0.00239	CcSEcCtD
Verapamil—Cardiac failure—Docetaxel—skin cancer	0.000341	0.00238	CcSEcCtD
Verapamil—KCNJ11—lymph node—skin cancer	0.00034	0.00546	CbGeAlD
Verapamil—Pruritus—Vemurafenib—skin cancer	0.00034	0.00238	CcSEcCtD
Verapamil—Lethargy—Docetaxel—skin cancer	0.000339	0.00238	CcSEcCtD
Verapamil—Alopecia—Dactinomycin—skin cancer	0.000338	0.00237	CcSEcCtD
Verapamil—Feeling abnormal—Imiquimod—skin cancer	0.000338	0.00237	CcSEcCtD
Verapamil—SLC22A1—head—skin cancer	0.000335	0.00538	CbGeAlD
Verapamil—Visual impairment—Temozolomide—skin cancer	0.000333	0.00233	CcSEcCtD
Verapamil—Sinusitis—Fluorouracil—skin cancer	0.000333	0.00233	CcSEcCtD
Verapamil—Diarrhoea—Vemurafenib—skin cancer	0.000329	0.0023	CcSEcCtD
Verapamil—Erythema multiforme—Temozolomide—skin cancer	0.000327	0.00229	CcSEcCtD
Verapamil—Urticaria—Imiquimod—skin cancer	0.000326	0.00228	CcSEcCtD
Verapamil—Tinnitus—Temozolomide—skin cancer	0.000322	0.00226	CcSEcCtD
Verapamil—SLCO1A2—head—skin cancer	0.000322	0.00518	CbGeAlD
Verapamil—Flushing—Temozolomide—skin cancer	0.000321	0.00225	CcSEcCtD
Verapamil—Rhinitis—Fluorouracil—skin cancer	0.000319	0.00224	CcSEcCtD
Verapamil—Dizziness—Vemurafenib—skin cancer	0.000318	0.00223	CcSEcCtD
Verapamil—Hypoaesthesia—Fluorouracil—skin cancer	0.000317	0.00222	CcSEcCtD
Verapamil—Pharyngitis—Fluorouracil—skin cancer	0.000316	0.00221	CcSEcCtD
Verapamil—CACNA1D—lymph node—skin cancer	0.000313	0.00503	CbGeAlD
Verapamil—SLC6A4—head—skin cancer	0.000311	0.005	CbGeAlD
Verapamil—ABCC4—head—skin cancer	0.00031	0.00498	CbGeAlD
Verapamil—CYP2B6—skin of body—skin cancer	0.00031	0.00497	CbGeAlD
Verapamil—ABCG2—mammalian vulva—skin cancer	0.000306	0.00491	CbGeAlD
Verapamil—Vomiting—Vemurafenib—skin cancer	0.000306	0.00214	CcSEcCtD
Verapamil—Alopecia—Temozolomide—skin cancer	0.000306	0.00214	CcSEcCtD
Verapamil—Myalgia—Bleomycin—skin cancer	0.000304	0.00213	CcSEcCtD
Verapamil—Chest pain—Bleomycin—skin cancer	0.000304	0.00213	CcSEcCtD
Verapamil—Orthostatic hypotension—Docetaxel—skin cancer	0.000304	0.00213	CcSEcCtD
Verapamil—Rash—Vemurafenib—skin cancer	0.000303	0.00212	CcSEcCtD
Verapamil—Dermatitis—Vemurafenib—skin cancer	0.000303	0.00212	CcSEcCtD
Verapamil—Hypersensitivity—Imiquimod—skin cancer	0.000302	0.00211	CcSEcCtD
Verapamil—Headache—Vemurafenib—skin cancer	0.000301	0.00211	CcSEcCtD
Verapamil—Discomfort—Bleomycin—skin cancer	0.0003	0.0021	CcSEcCtD
Verapamil—Cramp muscle—Docetaxel—skin cancer	0.000299	0.0021	CcSEcCtD
Verapamil—KCNH2—female reproductive system—skin cancer	0.000295	0.00473	CbGeAlD
Verapamil—Asthenia—Imiquimod—skin cancer	0.000294	0.00206	CcSEcCtD
Verapamil—Confusional state—Bleomycin—skin cancer	0.000294	0.00206	CcSEcCtD
Verapamil—Oedema—Bleomycin—skin cancer	0.000291	0.00204	CcSEcCtD
Verapamil—Anaphylactic shock—Bleomycin—skin cancer	0.000291	0.00204	CcSEcCtD
Verapamil—Pruritus—Imiquimod—skin cancer	0.00029	0.00203	CcSEcCtD
Verapamil—Infection—Bleomycin—skin cancer	0.000289	0.00203	CcSEcCtD
Verapamil—CACNA1C—lymph node—skin cancer	0.000289	0.00465	CbGeAlD
Verapamil—Nausea—Vemurafenib—skin cancer	0.000286	0.002	CcSEcCtD
Verapamil—Vision blurred—Temozolomide—skin cancer	0.000284	0.00199	CcSEcCtD
Verapamil—Myalgia—Dactinomycin—skin cancer	0.000283	0.00198	CcSEcCtD
Verapamil—Bronchospasm—Docetaxel—skin cancer	0.000283	0.00198	CcSEcCtD
Verapamil—Tremor—Temozolomide—skin cancer	0.000282	0.00197	CcSEcCtD
Verapamil—Alopecia—Fluorouracil—skin cancer	0.000282	0.00197	CcSEcCtD
Verapamil—Diarrhoea—Imiquimod—skin cancer	0.00028	0.00196	CcSEcCtD
Verapamil—Discomfort—Dactinomycin—skin cancer	0.00028	0.00196	CcSEcCtD
Verapamil—Angina pectoris—Docetaxel—skin cancer	0.00028	0.00196	CcSEcCtD
Verapamil—SLC22A5—female reproductive system—skin cancer	0.000278	0.00447	CbGeAlD
Verapamil—Agitation—Temozolomide—skin cancer	0.000277	0.00194	CcSEcCtD
Verapamil—Angioedema—Temozolomide—skin cancer	0.000275	0.00193	CcSEcCtD
Verapamil—Hypotension—Bleomycin—skin cancer	0.000272	0.00191	CcSEcCtD
Verapamil—Oedema—Dactinomycin—skin cancer	0.000272	0.0019	CcSEcCtD
Verapamil—Dizziness—Imiquimod—skin cancer	0.000271	0.0019	CcSEcCtD
Verapamil—Vertigo—Temozolomide—skin cancer	0.00027	0.00189	CcSEcCtD
Verapamil—Infection—Dactinomycin—skin cancer	0.00027	0.00189	CcSEcCtD
Verapamil—CYP2C8—female reproductive system—skin cancer	0.000269	0.00433	CbGeAlD
Verapamil—Palpitations—Temozolomide—skin cancer	0.000266	0.00186	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000265	0.00186	CcSEcCtD
Verapamil—ABCC3—lymph node—skin cancer	0.000263	0.00423	CbGeAlD
Verapamil—ABCC10—lymph node—skin cancer	0.000262	0.00421	CbGeAlD
Verapamil—Paraesthesia—Bleomycin—skin cancer	0.000262	0.00183	CcSEcCtD
Verapamil—Vision blurred—Fluorouracil—skin cancer	0.000261	0.00183	CcSEcCtD
Verapamil—Convulsion—Temozolomide—skin cancer	0.000261	0.00183	CcSEcCtD
Verapamil—Vomiting—Imiquimod—skin cancer	0.000261	0.00183	CcSEcCtD
Verapamil—Hypertension—Temozolomide—skin cancer	0.00026	0.00182	CcSEcCtD
Verapamil—Dyspnoea—Bleomycin—skin cancer	0.00026	0.00182	CcSEcCtD
Verapamil—Rash—Imiquimod—skin cancer	0.000258	0.00181	CcSEcCtD
Verapamil—Dermatitis—Imiquimod—skin cancer	0.000258	0.00181	CcSEcCtD
Verapamil—Headache—Imiquimod—skin cancer	0.000257	0.0018	CcSEcCtD
Verapamil—Arthralgia—Temozolomide—skin cancer	0.000256	0.00179	CcSEcCtD
Verapamil—Myalgia—Temozolomide—skin cancer	0.000256	0.00179	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000254	0.00178	CcSEcCtD
Verapamil—Discomfort—Temozolomide—skin cancer	0.000253	0.00177	CcSEcCtD
Verapamil—Acute coronary syndrome—Docetaxel—skin cancer	0.000253	0.00177	CcSEcCtD
Verapamil—Myocardial infarction—Docetaxel—skin cancer	0.000251	0.00176	CcSEcCtD
Verapamil—CYP2B6—lymphoid tissue—skin cancer	0.000251	0.00403	CbGeAlD
Verapamil—Dry mouth—Temozolomide—skin cancer	0.000251	0.00175	CcSEcCtD
Verapamil—Jaundice—Docetaxel—skin cancer	0.00025	0.00175	CcSEcCtD
Verapamil—Pain—Bleomycin—skin cancer	0.000249	0.00174	CcSEcCtD
Verapamil—Confusional state—Temozolomide—skin cancer	0.000248	0.00173	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000247	0.00173	CcSEcCtD
Verapamil—SLC22A4—lymph node—skin cancer	0.000246	0.00395	CbGeAlD
Verapamil—KCNH2—head—skin cancer	0.000246	0.00395	CbGeAlD
Verapamil—Oedema—Temozolomide—skin cancer	0.000246	0.00172	CcSEcCtD
Verapamil—Anaphylactic shock—Temozolomide—skin cancer	0.000246	0.00172	CcSEcCtD
Verapamil—Infection—Temozolomide—skin cancer	0.000244	0.00171	CcSEcCtD
Verapamil—Nausea—Imiquimod—skin cancer	0.000243	0.00171	CcSEcCtD
Verapamil—CYP2B6—female reproductive system—skin cancer	0.000242	0.00388	CbGeAlD
Verapamil—Convulsion—Fluorouracil—skin cancer	0.00024	0.00168	CcSEcCtD
Verapamil—Feeling abnormal—Bleomycin—skin cancer	0.00024	0.00168	CcSEcCtD
Verapamil—CYP2C9—female reproductive system—skin cancer	0.000239	0.00385	CbGeAlD
Verapamil—Hyperhidrosis—Temozolomide—skin cancer	0.000237	0.00166	CcSEcCtD
Verapamil—Chest pain—Fluorouracil—skin cancer	0.000236	0.00165	CcSEcCtD
Verapamil—Myalgia—Fluorouracil—skin cancer	0.000236	0.00165	CcSEcCtD
Verapamil—Fatigue—Dactinomycin—skin cancer	0.000234	0.00164	CcSEcCtD
Verapamil—Discomfort—Fluorouracil—skin cancer	0.000233	0.00163	CcSEcCtD
Verapamil—Pain—Dactinomycin—skin cancer	0.000232	0.00163	CcSEcCtD
Verapamil—Urticaria—Bleomycin—skin cancer	0.000231	0.00162	CcSEcCtD
Verapamil—Rhinitis—Docetaxel—skin cancer	0.000231	0.00161	CcSEcCtD
Verapamil—Hepatitis—Docetaxel—skin cancer	0.00023	0.00161	CcSEcCtD
Verapamil—Hypoaesthesia—Docetaxel—skin cancer	0.000229	0.0016	CcSEcCtD
Verapamil—Confusional state—Fluorouracil—skin cancer	0.000228	0.0016	CcSEcCtD
Verapamil—Pharyngitis—Docetaxel—skin cancer	0.000228	0.0016	CcSEcCtD
Verapamil—Oedema peripheral—Docetaxel—skin cancer	0.000227	0.00159	CcSEcCtD
Verapamil—Oedema—Fluorouracil—skin cancer	0.000226	0.00158	CcSEcCtD
Verapamil—Anaphylactic shock—Fluorouracil—skin cancer	0.000226	0.00158	CcSEcCtD
Verapamil—Infection—Fluorouracil—skin cancer	0.000225	0.00157	CcSEcCtD
Verapamil—Feeling abnormal—Dactinomycin—skin cancer	0.000224	0.00157	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000224	0.00157	CcSEcCtD
Verapamil—Insomnia—Temozolomide—skin cancer	0.000222	0.00156	CcSEcCtD
Verapamil—Visual impairment—Docetaxel—skin cancer	0.000222	0.00155	CcSEcCtD
Verapamil—Tachycardia—Fluorouracil—skin cancer	0.000221	0.00155	CcSEcCtD
Verapamil—Paraesthesia—Temozolomide—skin cancer	0.000221	0.00154	CcSEcCtD
Verapamil—Dyspnoea—Temozolomide—skin cancer	0.000219	0.00153	CcSEcCtD
Verapamil—Somnolence—Temozolomide—skin cancer	0.000218	0.00153	CcSEcCtD
Verapamil—Erythema multiforme—Docetaxel—skin cancer	0.000217	0.00152	CcSEcCtD
Verapamil—ABCC4—lymph node—skin cancer	0.000217	0.00349	CbGeAlD
Verapamil—Dyspepsia—Temozolomide—skin cancer	0.000216	0.00151	CcSEcCtD
Verapamil—Hypersensitivity—Bleomycin—skin cancer	0.000215	0.0015	CcSEcCtD
Verapamil—Flushing—Docetaxel—skin cancer	0.000213	0.00149	CcSEcCtD
Verapamil—Fatigue—Temozolomide—skin cancer	0.000212	0.00148	CcSEcCtD
Verapamil—Hypotension—Fluorouracil—skin cancer	0.000212	0.00148	CcSEcCtD
Verapamil—ABCC2—lymph node—skin cancer	0.00021	0.00338	CbGeAlD
Verapamil—Constipation—Temozolomide—skin cancer	0.00021	0.00147	CcSEcCtD
Verapamil—Pain—Temozolomide—skin cancer	0.00021	0.00147	CcSEcCtD
Verapamil—Asthenia—Bleomycin—skin cancer	0.000209	0.00146	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000206	0.00144	CcSEcCtD
Verapamil—Pruritus—Bleomycin—skin cancer	0.000206	0.00144	CcSEcCtD
Verapamil—Insomnia—Fluorouracil—skin cancer	0.000205	0.00143	CcSEcCtD
Verapamil—Paraesthesia—Fluorouracil—skin cancer	0.000203	0.00142	CcSEcCtD
Verapamil—Alopecia—Docetaxel—skin cancer	0.000203	0.00142	CcSEcCtD
Verapamil—Feeling abnormal—Temozolomide—skin cancer	0.000202	0.00142	CcSEcCtD
Verapamil—CYP2B6—head—skin cancer	0.000202	0.00324	CbGeAlD
Verapamil—Dyspnoea—Fluorouracil—skin cancer	0.000202	0.00141	CcSEcCtD
Verapamil—Somnolence—Fluorouracil—skin cancer	0.000201	0.00141	CcSEcCtD
Verapamil—Hypersensitivity—Dactinomycin—skin cancer	0.0002	0.0014	CcSEcCtD
Verapamil—Dyspepsia—Fluorouracil—skin cancer	0.000199	0.0014	CcSEcCtD
Verapamil—Urticaria—Temozolomide—skin cancer	0.000195	0.00137	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—skin cancer	0.000195	0.00136	CcSEcCtD
Verapamil—Pain—Fluorouracil—skin cancer	0.000194	0.00136	CcSEcCtD
Verapamil—Muscle spasms—Docetaxel—skin cancer	0.000192	0.00135	CcSEcCtD
Verapamil—Feeling abnormal—Fluorouracil—skin cancer	0.000187	0.00131	CcSEcCtD
Verapamil—Diarrhoea—Dactinomycin—skin cancer	0.000186	0.0013	CcSEcCtD
Verapamil—Vomiting—Bleomycin—skin cancer	0.000185	0.0013	CcSEcCtD
Verapamil—ABCC1—lymph node—skin cancer	0.000185	0.00297	CbGeAlD
Verapamil—Rash—Bleomycin—skin cancer	0.000184	0.00129	CcSEcCtD
Verapamil—Dermatitis—Bleomycin—skin cancer	0.000183	0.00128	CcSEcCtD
Verapamil—CYP3A4—female reproductive system—skin cancer	0.000183	0.00293	CbGeAlD
Verapamil—Hypersensitivity—Temozolomide—skin cancer	0.000181	0.00127	CcSEcCtD
Verapamil—Urticaria—Fluorouracil—skin cancer	0.00018	0.00126	CcSEcCtD
Verapamil—CYP2D6—female reproductive system—skin cancer	0.00018	0.00289	CbGeAlD
Verapamil—Syncope—Docetaxel—skin cancer	0.00018	0.00126	CcSEcCtD
Verapamil—Palpitations—Docetaxel—skin cancer	0.000177	0.00124	CcSEcCtD
Verapamil—Asthenia—Temozolomide—skin cancer	0.000176	0.00123	CcSEcCtD
Verapamil—Loss of consciousness—Docetaxel—skin cancer	0.000176	0.00123	CcSEcCtD
Verapamil—ABCB1—epithelium—skin cancer	0.000174	0.00279	CbGeAlD
Verapamil—Pruritus—Temozolomide—skin cancer	0.000174	0.00122	CcSEcCtD
Verapamil—Convulsion—Docetaxel—skin cancer	0.000173	0.00121	CcSEcCtD
Verapamil—Nausea—Bleomycin—skin cancer	0.000173	0.00121	CcSEcCtD
Verapamil—Hypertension—Docetaxel—skin cancer	0.000173	0.00121	CcSEcCtD
Verapamil—Vomiting—Dactinomycin—skin cancer	0.000173	0.00121	CcSEcCtD
Verapamil—KCNH2—lymph node—skin cancer	0.000172	0.00277	CbGeAlD
Verapamil—Rash—Dactinomycin—skin cancer	0.000171	0.0012	CcSEcCtD
Verapamil—Myalgia—Docetaxel—skin cancer	0.00017	0.00119	CcSEcCtD
Verapamil—Arthralgia—Docetaxel—skin cancer	0.00017	0.00119	CcSEcCtD
Verapamil—Chest pain—Docetaxel—skin cancer	0.00017	0.00119	CcSEcCtD
Verapamil—Diarrhoea—Temozolomide—skin cancer	0.000168	0.00118	CcSEcCtD
Verapamil—Hypersensitivity—Fluorouracil—skin cancer	0.000167	0.00117	CcSEcCtD
Verapamil—Dry mouth—Docetaxel—skin cancer	0.000167	0.00117	CcSEcCtD
Verapamil—Confusional state—Docetaxel—skin cancer	0.000165	0.00115	CcSEcCtD
Verapamil—Anaphylactic shock—Docetaxel—skin cancer	0.000163	0.00114	CcSEcCtD
Verapamil—Oedema—Docetaxel—skin cancer	0.000163	0.00114	CcSEcCtD
Verapamil—SLC22A5—lymph node—skin cancer	0.000163	0.00262	CbGeAlD
Verapamil—Dizziness—Temozolomide—skin cancer	0.000162	0.00114	CcSEcCtD
Verapamil—Infection—Docetaxel—skin cancer	0.000162	0.00114	CcSEcCtD
Verapamil—Nausea—Dactinomycin—skin cancer	0.000161	0.00113	CcSEcCtD
Verapamil—Shock—Docetaxel—skin cancer	0.000161	0.00113	CcSEcCtD
Verapamil—Pruritus—Fluorouracil—skin cancer	0.00016	0.00112	CcSEcCtD
Verapamil—Tachycardia—Docetaxel—skin cancer	0.000159	0.00112	CcSEcCtD
Verapamil—Vomiting—Temozolomide—skin cancer	0.000156	0.00109	CcSEcCtD
Verapamil—Rash—Temozolomide—skin cancer	0.000155	0.00108	CcSEcCtD
Verapamil—Diarrhoea—Fluorouracil—skin cancer	0.000155	0.00108	CcSEcCtD
Verapamil—Dermatitis—Temozolomide—skin cancer	0.000155	0.00108	CcSEcCtD
Verapamil—Headache—Temozolomide—skin cancer	0.000154	0.00108	CcSEcCtD
Verapamil—ABCG2—lymph node—skin cancer	0.000153	0.00246	CbGeAlD
Verapamil—Hypotension—Docetaxel—skin cancer	0.000153	0.00107	CcSEcCtD
Verapamil—ABCB1—mammalian vulva—skin cancer	0.000151	0.00242	CbGeAlD
Verapamil—CYP2D6—head—skin cancer	0.00015	0.00241	CbGeAlD
Verapamil—Dizziness—Fluorouracil—skin cancer	0.00015	0.00105	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000149	0.00104	CcSEcCtD
Verapamil—Insomnia—Docetaxel—skin cancer	0.000148	0.00103	CcSEcCtD
Verapamil—Paraesthesia—Docetaxel—skin cancer	0.000147	0.00103	CcSEcCtD
Verapamil—Nausea—Temozolomide—skin cancer	0.000146	0.00102	CcSEcCtD
Verapamil—Dyspnoea—Docetaxel—skin cancer	0.000146	0.00102	CcSEcCtD
Verapamil—Somnolence—Docetaxel—skin cancer	0.000145	0.00102	CcSEcCtD
Verapamil—Vomiting—Fluorouracil—skin cancer	0.000144	0.00101	CcSEcCtD
Verapamil—Dyspepsia—Docetaxel—skin cancer	0.000144	0.00101	CcSEcCtD
Verapamil—Rash—Fluorouracil—skin cancer	0.000143	0.000999	CcSEcCtD
Verapamil—Dermatitis—Fluorouracil—skin cancer	0.000143	0.000998	CcSEcCtD
Verapamil—Headache—Fluorouracil—skin cancer	0.000142	0.000993	CcSEcCtD
Verapamil—Fatigue—Docetaxel—skin cancer	0.000141	0.000986	CcSEcCtD
Verapamil—Constipation—Docetaxel—skin cancer	0.00014	0.000978	CcSEcCtD
Verapamil—Pain—Docetaxel—skin cancer	0.00014	0.000978	CcSEcCtD
Verapamil—Feeling abnormal—Docetaxel—skin cancer	0.000135	0.000943	CcSEcCtD
Verapamil—Nausea—Fluorouracil—skin cancer	0.000134	0.000941	CcSEcCtD
Verapamil—ABCB1—lymphoid tissue—skin cancer	0.000134	0.00215	CbGeAlD
Verapamil—ABCB1—female reproductive system—skin cancer	0.000129	0.00208	CbGeAlD
Verapamil—Hypersensitivity—Docetaxel—skin cancer	0.00012	0.000843	CcSEcCtD
Verapamil—Asthenia—Docetaxel—skin cancer	0.000117	0.000821	CcSEcCtD
Verapamil—Pruritus—Docetaxel—skin cancer	0.000116	0.000809	CcSEcCtD
Verapamil—Diarrhoea—Docetaxel—skin cancer	0.000112	0.000783	CcSEcCtD
Verapamil—Dizziness—Docetaxel—skin cancer	0.000108	0.000756	CcSEcCtD
Verapamil—ABCB1—head—skin cancer	0.000108	0.00173	CbGeAlD
Verapamil—Vomiting—Docetaxel—skin cancer	0.000104	0.000727	CcSEcCtD
Verapamil—Rash—Docetaxel—skin cancer	0.000103	0.000721	CcSEcCtD
Verapamil—Dermatitis—Docetaxel—skin cancer	0.000103	0.000721	CcSEcCtD
Verapamil—Headache—Docetaxel—skin cancer	0.000102	0.000717	CcSEcCtD
Verapamil—Nausea—Docetaxel—skin cancer	9.7e-05	0.000679	CcSEcCtD
Verapamil—ABCB1—lymph node—skin cancer	7.56e-05	0.00121	CbGeAlD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	3.66e-05	0.00113	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CSPG4—skin cancer	3.63e-05	0.00112	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PLIN2—skin cancer	3.62e-05	0.00111	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—BRAF—skin cancer	3.61e-05	0.00111	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—NRAS—skin cancer	3.61e-05	0.00111	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CSPG4—skin cancer	3.6e-05	0.00111	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—HRAS—skin cancer	3.54e-05	0.00109	CbGpPWpGaD
Verapamil—CACNB4—Axon guidance—IL6—skin cancer	3.54e-05	0.00109	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PLIN2—skin cancer	3.52e-05	0.00108	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—NRAS—skin cancer	3.5e-05	0.00108	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—KRAS—skin cancer	3.48e-05	0.00107	CbGpPWpGaD
Verapamil—CACNA1I—Axon guidance—HRAS—skin cancer	3.48e-05	0.00107	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—NRAS—skin cancer	3.39e-05	0.00105	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—NRAS—skin cancer	3.39e-05	0.00104	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—KRAS—skin cancer	3.38e-05	0.00104	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.38e-05	0.00104	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3.36e-05	0.00103	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—HRAS—skin cancer	3.33e-05	0.00103	CbGpPWpGaD
Verapamil—CACNA1I—Axon guidance—IL6—skin cancer	3.33e-05	0.00102	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—HRAS—skin cancer	3.24e-05	0.000998	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—CDK4—skin cancer	3.17e-05	0.000976	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CSPG4—skin cancer	3.17e-05	0.000975	CbGpPWpGaD
Verapamil—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	3.14e-05	0.000967	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—KRAS—skin cancer	3.1e-05	0.000956	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PLIN2—skin cancer	3.06e-05	0.000944	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.02e-05	0.000929	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—KRAS—skin cancer	3.02e-05	0.000929	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CDK4—skin cancer	3e-05	0.000924	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CSPG4—skin cancer	2.96e-05	0.000911	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—HRAS—skin cancer	2.96e-05	0.000911	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—KRAS—skin cancer	2.92e-05	0.0009	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—KRAS—skin cancer	2.92e-05	0.000899	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CSPG4—skin cancer	2.92e-05	0.000898	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—NRAS—skin cancer	2.88e-05	0.000888	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—NRAS—skin cancer	2.88e-05	0.000887	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—HRAS—skin cancer	2.88e-05	0.000886	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CSPG4—skin cancer	2.84e-05	0.000873	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—IL6—skin cancer	2.83e-05	0.000871	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—NRAS—skin cancer	2.81e-05	0.000864	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PLIN2—skin cancer	2.76e-05	0.000849	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—IL6—skin cancer	2.75e-05	0.000848	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.75e-05	0.000847	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	2.74e-05	0.000844	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CDK4—skin cancer	2.66e-05	0.000821	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—HRAS—skin cancer	2.66e-05	0.000818	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.65e-05	0.000818	CbGpPWpGaD
Verapamil—ABCC1—Disease—CSPG4—skin cancer	2.65e-05	0.000817	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—HRAS—skin cancer	2.64e-05	0.000813	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CDK4—skin cancer	2.64e-05	0.000812	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PLIN2—skin cancer	2.62e-05	0.000807	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—ERCC2—skin cancer	2.61e-05	0.000805	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.61e-05	0.000804	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	2.61e-05	0.000803	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ENO2—skin cancer	2.59e-05	0.000796	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—HRAS—skin cancer	2.56e-05	0.000789	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—IL6—skin cancer	2.53e-05	0.000779	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—IL6—skin cancer	2.53e-05	0.000778	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—NRAS—skin cancer	2.5e-05	0.00077	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—HRAS—skin cancer	2.48e-05	0.000765	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—KRAS—skin cancer	2.48e-05	0.000764	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—HRAS—skin cancer	2.48e-05	0.000764	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—KRAS—skin cancer	2.48e-05	0.000763	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CSPG4—skin cancer	2.47e-05	0.000761	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—NRAS—skin cancer	2.47e-05	0.00076	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ENO2—skin cancer	2.47e-05	0.00076	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—ERCC2—skin cancer	2.46e-05	0.000757	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—IL6—skin cancer	2.45e-05	0.000756	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ENO2—skin cancer	2.45e-05	0.000754	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PLIN2—skin cancer	2.43e-05	0.000747	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—NRAS—skin cancer	2.42e-05	0.000746	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—KRAS—skin cancer	2.41e-05	0.000744	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PLIN2—skin cancer	2.4e-05	0.000741	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—IL6—skin cancer	2.38e-05	0.000732	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—IL6—skin cancer	2.37e-05	0.000731	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.35e-05	0.000724	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—NRAS—skin cancer	2.34e-05	0.00072	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—IL6—skin cancer	2.28e-05	0.000701	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.25e-05	0.000692	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PLIN2—skin cancer	2.24e-05	0.000689	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CSPG4—skin cancer	2.22e-05	0.000684	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—KRAS—skin cancer	2.15e-05	0.000663	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ENO2—skin cancer	2.15e-05	0.000663	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—KRAS—skin cancer	2.12e-05	0.000654	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CSPG4—skin cancer	2.11e-05	0.00065	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—HRAS—skin cancer	2.11e-05	0.00065	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—HRAS—skin cancer	2.11e-05	0.000649	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—BRAF—skin cancer	2.1e-05	0.000647	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—KRAS—skin cancer	2.08e-05	0.000642	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—NRAS—skin cancer	2.08e-05	0.000639	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—NRAS—skin cancer	2.05e-05	0.000633	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—NRAS—skin cancer	2.05e-05	0.000633	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—HRAS—skin cancer	2.05e-05	0.000632	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—HRAS—skin cancer	2.04e-05	0.000627	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—skin cancer	2.03e-05	0.000625	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—IL6—skin cancer	2.02e-05	0.000622	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—IL6—skin cancer	2.02e-05	0.000621	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—KRAS—skin cancer	2.01e-05	0.00062	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ENO2—skin cancer	2.01e-05	0.000619	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ENO2—skin cancer	1.98e-05	0.00061	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—IL6—skin cancer	1.96e-05	0.000605	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CSPG4—skin cancer	1.96e-05	0.000602	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—HRAS—skin cancer	1.94e-05	0.000598	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CSPG4—skin cancer	1.94e-05	0.000597	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ENO2—skin cancer	1.93e-05	0.000594	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.91e-05	0.000588	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.88e-05	0.00058	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—IL6—skin cancer	1.86e-05	0.000573	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—HRAS—skin cancer	1.83e-05	0.000563	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—HRAS—skin cancer	1.81e-05	0.000556	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CSPG4—skin cancer	1.8e-05	0.000556	CbGpPWpGaD
Verapamil—ABCC1—Disease—SHH—skin cancer	1.8e-05	0.000556	CbGpPWpGaD
Verapamil—ABCC1—Disease—ENO2—skin cancer	1.8e-05	0.000556	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—KRAS—skin cancer	1.79e-05	0.00055	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PLIN2—skin cancer	1.78e-05	0.000548	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—HRAS—skin cancer	1.77e-05	0.000546	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—KRAS—skin cancer	1.77e-05	0.000545	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—KRAS—skin cancer	1.77e-05	0.000545	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—NRAS—skin cancer	1.76e-05	0.000543	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—IL6—skin cancer	1.75e-05	0.000539	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PLIN2—skin cancer	1.74e-05	0.000535	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—IL6—skin cancer	1.73e-05	0.000532	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—HRAS—skin cancer	1.71e-05	0.000527	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—IL6—skin cancer	1.7e-05	0.000522	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ENO2—skin cancer	1.68e-05	0.000517	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—NRAS—skin cancer	1.67e-05	0.000514	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—HRAS—skin cancer	1.66e-05	0.000511	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—IL6—skin cancer	1.64e-05	0.000504	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.57e-05	0.000484	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PTGS2—skin cancer	1.57e-05	0.000483	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—HRAS—skin cancer	1.52e-05	0.000468	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—KRAS—skin cancer	1.52e-05	0.000467	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ENO2—skin cancer	1.51e-05	0.000465	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.51e-05	0.000464	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PLIN2—skin cancer	1.51e-05	0.000464	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—HRAS—skin cancer	1.5e-05	0.000463	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—HRAS—skin cancer	1.5e-05	0.000463	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ERCC2—skin cancer	1.5e-05	0.000463	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NRAS—skin cancer	1.48e-05	0.000456	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTGS2—skin cancer	1.47e-05	0.000454	CbGpPWpGaD
Verapamil—ABCC1—Disease—FOXO4—skin cancer	1.47e-05	0.000453	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NRAS—skin cancer	1.47e-05	0.000451	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—IL6—skin cancer	1.45e-05	0.000448	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—IL6—skin cancer	1.44e-05	0.000443	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—IL6—skin cancer	1.44e-05	0.000443	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—KRAS—skin cancer	1.44e-05	0.000442	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ENO2—skin cancer	1.44e-05	0.000442	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CSPG4—skin cancer	1.43e-05	0.000441	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ERCC2—skin cancer	1.43e-05	0.000441	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ERCC2—skin cancer	1.42e-05	0.000438	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CSPG4—skin cancer	1.4e-05	0.000431	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.35e-05	0.000415	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PLIN2—skin cancer	1.34e-05	0.000414	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ENO2—skin cancer	1.33e-05	0.000409	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ENO2—skin cancer	1.32e-05	0.000406	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.31e-05	0.000404	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PLIN2—skin cancer	1.31e-05	0.000404	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—HRAS—skin cancer	1.29e-05	0.000397	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—KRAS—skin cancer	1.28e-05	0.000393	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—KRAS—skin cancer	1.26e-05	0.000389	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	1.26e-05	0.000388	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ERCC2—skin cancer	1.25e-05	0.000385	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PLIN2—skin cancer	1.24e-05	0.000381	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—IL6—skin cancer	1.23e-05	0.00038	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ENO2—skin cancer	1.23e-05	0.000378	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PLIN2—skin cancer	1.23e-05	0.000377	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—HRAS—skin cancer	1.22e-05	0.000376	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CSPG4—skin cancer	1.21e-05	0.000374	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NRAS—skin cancer	1.21e-05	0.000373	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.18e-05	0.000364	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—IL6—skin cancer	1.17e-05	0.00036	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ERCC2—skin cancer	1.17e-05	0.00036	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ERCC2—skin cancer	1.15e-05	0.000355	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.12e-05	0.000346	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ERCC2—skin cancer	1.12e-05	0.000345	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—skin cancer	1.08e-05	0.000334	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CSPG4—skin cancer	1.08e-05	0.000334	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—skin cancer	1.07e-05	0.00033	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CSPG4—skin cancer	1.06e-05	0.000326	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERCC2—skin cancer	1.05e-05	0.000323	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PLIN2—skin cancer	1.05e-05	0.000322	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—KRAS—skin cancer	1.04e-05	0.000321	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—IL6—skin cancer	1.04e-05	0.00032	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—IL6—skin cancer	1.03e-05	0.000316	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CSPG4—skin cancer	9.96e-06	0.000307	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CSPG4—skin cancer	9.88e-06	0.000304	CbGpPWpGaD
Verapamil—ABCC1—Disease—TERT—skin cancer	9.82e-06	0.000302	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ERCC2—skin cancer	9.75e-06	0.0003	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ENO2—skin cancer	9.74e-06	0.0003	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—skin cancer	9.65e-06	0.000297	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ENO2—skin cancer	9.52e-06	0.000293	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—skin cancer	9.27e-06	0.000285	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	9.01e-06	0.000278	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—skin cancer	9.01e-06	0.000277	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—skin cancer	8.86e-06	0.000273	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ERCC2—skin cancer	8.77e-06	0.00027	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—skin cancer	8.59e-06	0.000265	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—skin cancer	8.53e-06	0.000263	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CSPG4—skin cancer	8.44e-06	0.00026	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ERCC2—skin cancer	8.34e-06	0.000257	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO2—skin cancer	8.25e-06	0.000254	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLIN2—skin cancer	8.08e-06	0.000249	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	8.01e-06	0.000247	CbGpPWpGaD
Verapamil—ABCC1—Disease—BRAF—skin cancer	7.78e-06	0.00024	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ERCC2—skin cancer	7.72e-06	0.000238	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ERCC2—skin cancer	7.65e-06	0.000236	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—skin cancer	7.49e-06	0.000231	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO2—skin cancer	7.36e-06	0.000227	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO2—skin cancer	7.19e-06	0.000221	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ERCC2—skin cancer	7.12e-06	0.000219	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—skin cancer	7e-06	0.000216	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—skin cancer	6.9e-06	0.000213	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO2—skin cancer	6.77e-06	0.000209	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—skin cancer	6.71e-06	0.000207	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO2—skin cancer	6.71e-06	0.000207	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CSPG4—skin cancer	6.51e-06	0.000201	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.45e-06	0.000199	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—skin cancer	6.28e-06	0.000193	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—skin cancer	5.85e-06	0.00018	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.76e-06	0.000177	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO2—skin cancer	5.74e-06	0.000177	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ERCC2—skin cancer	5.66e-06	0.000174	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ERCC2—skin cancer	5.53e-06	0.00017	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—skin cancer	5.26e-06	0.000162	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.25e-06	0.000162	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—skin cancer	5e-06	0.000154	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—skin cancer	4.89e-06	0.000151	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ERCC2—skin cancer	4.79e-06	0.000148	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—skin cancer	4.63e-06	0.000143	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—skin cancer	4.59e-06	0.000141	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.49e-06	0.000138	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO2—skin cancer	4.43e-06	0.000136	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ERCC2—skin cancer	4.28e-06	0.000132	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—skin cancer	4.27e-06	0.000132	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—skin cancer	4.21e-06	0.00013	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ERCC2—skin cancer	4.17e-06	0.000129	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ERCC2—skin cancer	3.93e-06	0.000121	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ERCC2—skin cancer	3.9e-06	0.00012	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—skin cancer	3.58e-06	0.00011	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—skin cancer	3.42e-06	0.000105	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—skin cancer	3.39e-06	0.000105	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ERCC2—skin cancer	3.33e-06	0.000103	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—skin cancer	3.32e-06	0.000102	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—skin cancer	2.87e-06	8.85e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ERCC2—skin cancer	2.57e-06	7.92e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—skin cancer	2.56e-06	7.9e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—skin cancer	2.5e-06	7.71e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—skin cancer	2.36e-06	7.26e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—skin cancer	2.34e-06	7.2e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—skin cancer	2e-06	6.15e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—skin cancer	1.54e-06	4.75e-05	CbGpPWpGaD
